Post-traumatic and postoperative pain syndromes accompanied by inflammation and swelling, for example, following dental and orthopedic procedures.
Active substance: Diclofenac sodium.
Each tablet contains 25 mg of diclofenac sodium.
Excipients: Lactose monohydrate, potato starch, povidone, magnesium stearate, methacrylate copolymer dispersion, propylene glycol, talc, titanium dioxide (E171), Sunset Yellow FCF (E110).
Inflammatory and degenerative forms of rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondyloarthritis); pain syndromes of the spine; extra-articular rheumatic disorders of the soft tissues; acute attacks of gout; post-traumatic and postoperative pain syndromes accompanied by inflammation and swelling, for example after dental or orthopedic procedures; gynecological disorders accompanied by pain and inflammation, such as primary dysmenorrhea or adnexitis; as an adjunct in the treatment of severe inflammatory disorders of the ear, nose and throat associated with pronounced pain, such as pharyngotonsillitis and otitis.
In accordance with the general principles of therapy, the underlying disease should be treated with appropriate basic therapy. Fever alone is not an indication for the use of this medicinal product.
Hypersensitivity to the active substance or to any of the other components of the medicinal product.
History of gastrointestinal bleeding or perforation related to previous treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
Active peptic ulcer disease/bleeding or a history of recurrent peptic ulcer disease/bleeding (two or more distinct episodes of confirmed ulceration or bleeding).
Last trimester of pregnancy.
Inflammatory bowel disease (e.g. Crohn's disease or ulcerative colitis).
Hepatic impairment.
Renal impairment.
Congestive heart failure (NYHA Class IIโIV).
Treatment of perioperative pain associated with coronary artery bypass graft (CABG) surgery (or use of cardiopulmonary bypass).
Ischemic heart disease in patients with angina pectoris or previous myocardial infarction.
Cerebrovascular disease in patients with a history of stroke or transient ischemic attacks (TIAs).
Peripheral arterial disease.
Like other NSAIDs, Orthophen is contraindicated in patients in whom ibuprofen, acetylsalicylic acid (aspirin), or other NSAIDs have induced attacks of bronchial asthma, angioedema, urticaria, acute rhinitis, nasal polyps, or other allergic reactions.
Treatment should be initiated as soon as possible after the first symptoms of pain appear. Depending on the symptoms, the duration of treatment may range from several days.
The medicinal product should be administered at the lowest effective dose for the shortest possible duration, taking into account the treatment goals for each individual patient.
The recommended initial dose for adults is 100โ150 mg daily. In milder cases, as well as during long-term therapy, a daily dose of 75โ100 mg is usually sufficient.
The total daily dose for adults should generally be divided into 2โ3 doses. The daily dose should not exceed 150 mg.
In primary dysmenorrhea, the daily dose should be individualized and usually ranges from 50โ150 mg. The initial dose may be 50โ100 mg and, if necessary, may be increased over several menstrual cycles, but should not exceed 200 mg per day.
Children aged 8 years and older (weighing at least 25 kg) up to 14 years of age should receive 25 mg tablets as prescribed by a physician at a daily dose of 1โ2 mg/kg body weight, depending on the severity of symptoms. This dose should be divided into 2โ3 administrations.
For example, a child weighing 30 kg may receive a daily dose of 30โ60 mg. Based on this range, the child may be prescribed one 25 mg tablet twice daily.
For the treatment of juvenile rheumatoid arthritis, the dose may be increased up to 3 mg/kg/day. The maximum daily dose should not exceed 150 mg.
Children:
For children aged 8 years and older (weighing at least 25 kg) up to 14 years of age, the medicinal product should be prescribed only in the form of 25 mg tablets. Children aged 14 years and older may be prescribed 50 mg tablets.
Store in the original package at a temperature not exceeding 25ยฐC.
Keep out of the reach of children.